The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for MG Caron


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of an affinity ligand for purification of alpha 2-adrenoceptors from human platelet membranes.EBI
TBA
Design, synthesis, and analysis of antagonists of GPR55: Piperidine-substituted 1,3,4-oxadiazol-2-ones.EBI
University of North Carolina At Greensboro
Imidazole-derived agonists for the neurotensin 1 receptor.EBI
Sanford-Burnham Medical Research Institute
Discovery of ML314, a Brain Penetrant Non-Peptidicβ-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor.EBI
Sanford-Burnham Medical Research Institute
Novel adamantyl cannabinoids as CB1 receptor probes.EBI
Northeastern University
Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine DEBI
University of North Carolina at Chapel Hill
Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators.EBI
Sanford Burnham Prebys Medical Discovery Institute
Design, synthesis and biological evaluation of GPR55 agonists.EBI
University of North Carolina At Greensboro
Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideBDB
Exelixis
Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands.BDB
Monash University
Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.BDB
Merck Research Laboratories